| Novel nanomaterials for clinical neuroscience JL Gilmore, X Yi, L Quan, AV Kabanov Journal of NeuroImmune Pharmacology 3 (2), 83-94, 2008 | 241 | 2008 |
| Synthesis and biological evaluation of substituted 2-sulfonyl-phenyl-3-phenyl-indoles: a new series of selective COX-2 inhibitors W Hu, Z Guo, F Chu, A Bai, X Yi, G Cheng, J Li Bioorganic & medicinal chemistry 11 (7), 1153-1160, 2003 | 131 | 2003 |
| Agile delivery of protein therapeutics to CNS X Yi, DS Manickam, A Brynskikh, AV Kabanov Journal of Controlled Release 190, 637-663, 2014 | 113 | 2014 |
| Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly (2-oxazoline) s nanoformulation J Tong, MC Zimmerman, S Li, X Yi, R Luxenhofer, R Jordan, AV Kabanov Biomaterials 32 (14), 3654-3665, 2011 | 110 | 2011 |
| Transport across the blood-brain barrier of pluronic leptin TO Price, SA Farr, X Yi, S Vinogradov, E Batrakova, WA Banks, ... Journal of Pharmacology and Experimental Therapeutics 333 (1), 253-263, 2010 | 92 | 2010 |
| Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery NM Harris, R Ritzel, NS Mancini, Y Jiang, X Yi, DS Manickam, WA Banks, ... Pharmacology Biochemistry and Behavior 150, 48-56, 2016 | 83 | 2016 |
| Conjugates of superoxide dismutase 1 with amphiphilic poly (2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and … J Tong, X Yi, R Luxenhofer, WA Banks, R Jordan, MC Zimmerman, ... Molecular pharmaceutics 10 (1), 360-377, 2013 | 83 | 2013 |
| Protein modification with amphiphilic block copoly (2-oxazoline) s as a new platform for enhanced cellular delivery J Tong, R Luxenhofer, X Yi, R Jordan, AV Kabanov Molecular pharmaceutics 7 (4), 984-992, 2010 | 83 | 2010 |
| Intranasal administration as a route for drug delivery to the brain: evidence for a unique pathway for albumin JA Falcone, TS Salameh, X Yi, BJ Cordy, WG Mortell, AV Kabanov, ... Journal of Pharmacology and Experimental Therapeutics 351 (1), 54-60, 2014 | 68 | 2014 |
| Small-sized mPEG–PLGA nanoparticles of Schisantherin A with sustained release for enhanced brain uptake and anti-parkinsonian activity T Chen, C Li, Y Li, X Yi, R Wang, SMY Lee, Y Zheng ACS applied materials & interfaces 9 (11), 9516-9527, 2017 | 67 | 2017 |
| Discovery of 2-Phenyl-3-sulfonylphenyl-indole derivatives as a new class of selective COX-2 inhibitors W Hu, Z Guo, X Yi, C Guo, F Chu, G Cheng Bioorganic & medicinal chemistry 11 (24), 5539-5544, 2003 | 66 | 2003 |
| Zebrafish: A promising in vivo model for assessing the delivery of natural products, fluorescence dyes and drugs across the blood-brain barrier Y Li, T Chen, X Miao, X Yi, X Wang, H Zhao, SMY Lee, Y Zheng Pharmacological research 125, 246-257, 2017 | 62 | 2017 |
| Pluronic-modified superoxide dismutase 1 attenuates angiotensin II-induced increase in intracellular superoxide in neurons X Yi, MC Zimmerman, R Yang, J Tong, S Vinogradov, AV Kabanov Free Radical Biology and Medicine 49 (4), 548-558, 2010 | 61 | 2010 |
| Nanoformulation of brain‐derived neurotrophic factor with target receptor‐triggered‐release in the central nervous system Y Jiang, JM Fay, CD Poon, N Vinod, Y Zhao, K Bullock, S Qin, ... Advanced functional materials 28 (6), 1703982, 2018 | 60 | 2018 |
| Protein conjugation with amphiphilic block copolymers for enhanced cellular delivery X Yi, E Batrakova, WA Banks, S Vinogradov, AV Kabanov Bioconjugate chemistry 19 (5), 1071-1077, 2008 | 55 | 2008 |
| Oral delivery of a nanocrystal formulation of schisantherin a with improved bioavailability and brain delivery for the treatment of Parkinson’s disease T Chen, C Li, Y Li, X Yi, SMY Lee, Y Zheng Molecular pharmaceutics 13 (11), 3864-3875, 2016 | 46 | 2016 |
| Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity X Yi, D Yuan, SA Farr, WA Banks, CD Poon, AV Kabanov Journal of Controlled Release 191, 34-46, 2014 | 45 | 2014 |
| Study on molecular mechanism and 3D-QSAR of influenza neuraminidase inhibitors X Yi, Z Guo, FM Chu Bioorganic & medicinal chemistry 11 (7), 1465-1474, 2003 | 42 | 2003 |
| Zebrafish as a visual and dynamic model to study the transport of nanosized drug delivery systems across the biological barriers Y Li, X Miao, T Chen, X Yi, R Wang, H Zhao, SMY Lee, X Wang, Y Zheng Colloids and Surfaces B: Biointerfaces 156, 227-235, 2017 | 36 | 2017 |
| Principles of strategic drug delivery to the brain (SDDB): development of anorectic and orexigenic analogs of leptin WA Banks, A Gertler, G Solomon, L Niv-Spector, M Shpilman, X Yi, ... Physiology & behavior 105 (1), 145-149, 2011 | 33 | 2011 |
